Introduction
Prion diseases, such as scrapie, have long been thought to affect mainly sheep and some exotic animals, such as elk and mink. The epidemiology of human prion diseases is confined to Creutzfeldt-Jakob disease and related ailments, which are exceedingly rare, and to Kuru, which is unlikely to represent a danger to humans unless one indulges in cannibalism. However, a new variant of Creutzfeldt-Jakob disease (nvCJD) is now occurring in humans, which is thought to result from the ingestion of products contaminated with bovine spongiform encephalopathy (BSE). At the time of writing, only two dozen individuals have succumbed to nvCJD, but because many persons may have been exposed to the BSE agent, a thorough understanding of transmissible spongiform encephalopathies is clearly needed [1, 2] .
Two as yet unresolved questions continue to occupy the attention of researchers in the field. The first relates to the actual structure of the infectious agent, which has been named a prion and which replicates in the central nervous system (CNS) and in some other tissues of infected animals and humans.
We have dealt with these issues in several recent review articles [1] , and therefore will not focus on this discussion here.
The second question is no less intriguing: by which mechanisms can prions bring about damage to the CNS? Is the damage related to the actual replication of the prion? Or is the spongiform encephalopathy a result of the accumulation of toxic metabolites within, or around, neurons? One prime candidate for the toxicity hypothesis is certainly PrP Sc , the pathologically changed isoform of the normal prion protein PrP C . But is PrP Sc toxic only if it is generated within cells, or can it damage nerve cells when acting from without? In addition, since prions appear to replicate in the organs of the lymphoreticular system, such as the spleen, lymph nodes and Peyer's plaques of the intestine, why are immune deficiencies or damage to these organs not encountered after infection with prions? In other words, is susceptibility to prion toxicity a unique property of neural tissue, or is it rather the result of the much higher levels of PrP Sc accumulation seen in the brains, as compared with the lymphoreticular organs, of terminally sick scrapie mice?
It may be very difficult to devise suitable systems to address these issues experimentally. However, the recent generation of transgenic and knock-out mice for the Prnp gene has opened up new, promising avenues of investigation. We have taken advantage of various strains of transgenic mice, and have asked whether neurografting technology could be used to address the question of prion neurotoxicity.
Neural grafting (described in the next section) has often been used to address questions related to developmental neurobiology. Several studies have investigated the establishment of neuronal organization within grafts and interactions with the host. Recent grafting studies have been aimed at questions related to neural plasticity; for example, whether and to what extent undifferentiated progenitor cells could integrate and participate in the formation of the host CNS [3] .
In the field of neurodegenerative disorders, grafting studies have been aimed mainly at reconstituting certain pathways or particular functions after surgical or toxic lesions to selected functional systems. In these models, an artificial lesion leads to the degeneration of specific neuronal systems. Grafting of neural tissue or genetically engineered cells aims at the functional repair of induced lesions [4] . Many such experiments have been carried out in the rat system, which is well suited for developmental studies and allows stereotaxic surgical interventions (where specific anatomical regions can be targeted following calculation of the co-ordinates) to be carried out with appropriate accuracy.
In this overview, we describe the biological properties of neuroepithelial grafts, such as tissue growth, proliferation and differentiation. Special emphasis is placed on the development of the blood-brain barrier (BBB) after grafting. We then describe how embryonic telencephalic grafting has been applied to the study of scrapie pathogenesis.
Biological characteristics of mouse neuroectodermal grafts
Transgenic techniques facilitate the study of the role of single molecules in development, and in functional and pathological processes. The generation of knock-out mice by the targeted deletion of genes of interest has expanded our understanding of the molecular mechanisms of neural development and the pathogenesis of CNS diseases. Transgenic and knock-out mice have provided valuable models for neurodegenerative diseases [5] [6] [7] . Others, however, show early postnatal [8] [9] [10] or even embryonic [11, 12] lethal phenotypes which can be difficult to interpret. Lethal phenotypes provide strong evidence for a crucial role for the respective gene products during development, and hint at an important role for these factors in the determination of cell fates during differentiation [12-14,14a ], but they do not allow us to study the roles that these factors play in secondary pathological processes such as neurodegeneration. In an effort to overcome this problem, we have employed transplantation approaches using neural tissue derived from such mouse embryos. Using grafting techniques, it has been possible to study the neural tissue of mice with premature lethal genotypes at time points that exceed by far the life span of the mutant mice [14,14a,15] .
For the grafting procedure, neuroectodermal tissue is harvested from a mouse and implanted stereotaxically into the caudoputamen of recipient mice. Such neurografts contain neurons with myelinated processes and a dense synaptic network, glia (astrocytes, oligodendrocytes and microglia) and blood vessels 4 weeks after grafting (projected age of grafted tissue is approximately postnatal day 20) [14,14a,15] . Taken together, these findings indicate that embryonic neuroepithelial tissue grafted into an adult host brain follows a programme of maturation and differentiation with a time course similar to that occurring in vivo [14,14a] .
Blood-brain barrier and brain grafts
The BBB maintains the homoeostatic environment in the brain by preventing blood-borne compounds gaining free entry into the CNS parenchyma. The barrier is formed by tight junctions in the vascular endothelia, which are probably induced by astrocytes. A number of pathological CNS processes, such as inflammation, demyelination, tumour growth or degeneration, can induce breakdown of the BBB. In turn, BBB leakage might induce CNS dysfunction caused by blood-borne neurotoxic compounds that are normally excluded from the brain parenchyma [16] .
The post-transplantation status of the BBB in rodents is still controversial. An early, yet most valuable, study suggested that the type of donor tissue determines the characteristics and BBB properties of vessels supplying the graft [17] . According to this hypothesis, neural grafts induce BBB properties in the supplying blood vessels. In fact, several authors have described complete BBB reconstitution after neural grafting to the CNS. Some even found no residual BBB leakage as early as 1 week after grafting [18] . We carried out studies in the model described using four independent marker molecules to detect damage to the BBB. The results obtained with various techniques were consistent. Both magnetic resonance imaging (MRI) and histological analysis indicated that the BBB was reconstituted in 67% of all grafts after 3 weeks, and in 90% of the grafts 7 weeks after grafting. These findings indicate that the grafting procedure usually does not induce permanent BBB leakage that might expose the grafted tissue to a non-physiological environment, and suggest that the genotype of the grafted tissue determines the BBB properties of the graft.
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Figure 1. Use of the neurografting technique for the study of mouse scrapie
The neuroectodermal anlage from a PrP C -overexpressing mouse (designated tga20) was implanted into the brain of a PrP-deficient knock-out mouse, and prions were administered intracerebrally. After an incubation time of at least 10 weeks, the brains were assayed for the presence of proteinase-resistant PrP and for infectivity. Titration for the determination of infectivity is performed by scratching graft tissue from cryosections, homogenization and intracerebral injection into PrP-overexpressing tga20 mice. The presence of proteinase-resistant PrP is detected by immunohistochemistry of adjacent sections.
Mating of Prnp-tga20 donor mice (overexpressing PrP C )
Harvest embryos at day 12.5-13. 
Neurografts in prion research
We decided to apply the grafting technique to the study of scrapie. Prnp o/o mice, which are devoid of PrP C , are resistant to scrapie and do not propagate prions [5, 19] . Because these mice show normal development and behaviour [20] , it has been argued that scrapie pathology may come about because PrP Sc deposition is neurotoxic [21] , rather than due to the depletion of cellular PrP C . On the other hand, the acute depletion of PrP C might be much more deleterious than its absence throughout development, since the organism may then not have time to activate compensatory mechanisms.
One way to address the question of neurotoxicity was to expose brain tissue of Prnp o/o mice to a continuous source of PrP Sc . We therefore grafted neural tissue overexpressing PrP into the brains of PrP-deficient mice ( Figure 1 ). After intracerebral inoculation of scrapie prions, the grafts accumulated high levels of PrP Sc and infectivity (Table 1) , and developed severe histopathological changes characteristic of scrapie. Substantial amounts of graft-derived PrP Sc migrated into the host brains ( [22,22a,23] ; see also Figure 1 ). However, even 16 months after transplantation and infection with prions, no pathological changes were detected in the PrP-deficient recipient tissue, even in the immediate vicinity of the grafts. Such results suggest that PrP Sc is inherently non-toxic and that PrP Sc plaques found in spongiform encephalopathies may be an epiphenomenon rather than a cause of neuronal damage. It is conceivable that PrP Sc is only toxic when it is formed and accumulated within the cell, but not when presented from outside. Finally, it may be that PrP Sc is pathogenic when presented from without, but only to cells expressing PrP C , either because it initiates conversion of PrP C into PrP Sc at the cell surface and/or because it is internalized in association with PrP C , which is endocytosed efficiently [24] . The fact that a scrapie-infected host animal harbouring a neuroectodermal graft does not develop clinical signs of scrapie allowed investigation of the pathological chain of events leading to neurodegeneration, and determination of the end point of the disease. Based on morphological criteria, it was found that, with increasing incubation periods, grafts underwent progressive astrogliosis and spongiosis, which were accompanied by loss of neuronal processes within the grafts and subsequent destruction of the neuropil (see below).
Spread of prions in the CNS
Intracerebral inoculation of tissue homogenate into suitable recipients is the most effective method for the transmission of spongiform encephalopathies. However, spongiform encephalopathies have also been transmitted by feeding, as well as by intravenous, intraperitoneal and intramuscular injection. Prion diseases can also be initiated from the eye by conjunctival instillation, corneal grafts and intraocular injection [25] . The latter method has proved particularly useful in studying the neural spread of the agent, since the retina is a part of the CNS, and intraocular injection leads to the progressive appearance of pathological changes typical of scrapie along the optic tract, the lateral geniculate nucleus and the superior colliculus; eventually the CNS is colonized, leading to generalized spongiform encephalopathy (Figures 2b-2d) .
To determine whether the spread of prions along the optic pathway is dependent on the presence of PrP C , we again used grafting technology. This time, the neural grafts served as indicators of the transport of prion infectivity from the retina to the CNS. After intraocular inoculation, Prnp o/o mice grafted with Prnp-overexpressing tissue were allowed to survive for up to 1.5 years. Even at this time, none of the mice showed any sign of spongiform encephalopathy in their grafts. Therefore PrP C appears to be necessary for the spread of prions from the eye to the rest of the CNS.
Engraftment of Prnp o/o mice with PrP C -producing tissue may conceivably lead to an immune response to PrP [26] , and possibly to neutralization of infectivity. Indeed, sera from grafted mice had significant anti-PrP antibody titres. To test whether grafts would develop scrapie if infectivity were administered before the establishment of an immune response, we inoculated mice 24 h after grafting. Again, no disease was detected in the grafts of two mice inoculated intraocularly.
In order to rule out definitively the possibility that prion transport had been disabled by a neutralizing immune response, we repeated the experiments in mice largely tolerant of PrP. For this, we introduced a transgene into Prnp o/o mice that led to the overexpression of PrP on T-lymphocytes. These mice were still resistant to scrapie and, when engrafted with PrP C -overexpressing neuroectoderm, did not develop antibodies to PrP, presumably due to the clonal deletion of PrP-immunoreactive lymphocytes. As before, intraocular inoculation with prions did not provoke scrapie in the graft, supporting the conclusion that lack of PrP C , rather than an immune response to PrP, prevents spread.
Pathological findings characteristic of scrapie, and replication of infectivity after intraocular injection, occur along the anatomical structures of the visual system [25] and spread to trans-synaptic structures (such as the contralateral superior colliculus, lateral geniculate nucleus and visual cortex; see Figure 2b ). This has been taken as evidence for axonal transport of the agent. However, although PrP C seems to travel with fast axonal transport [27] , the very slow kinetics of disease development caused by prions suggests a different mode of spread for infectious prions. Since intraocular inoculation failed to infect grafts even in the absence of an immune response to PrP (Figures 2i and 2k) , PrP C appears to be necessary for the spread of prions along the retinal projections and within the intact CNS. The prion itself seems, therefore, to be surprisingly sessile.
Since prion infectivity is consistently detectable in the spleen earlier than in the brain, even after intracerebral inoculation [28] , it could be argued that prion replication in lymphoreticular organs may be involved in the neuroinvasiveness of intraocularly administered prions. Enucleation as late as 7 days following intraocular inoculation resulted in scrapie, but prevented targeting to the visual system [29] . This suggests that systemic infection and secondary neuroinvasion can bypass the neural spread of prions if the visual pathway is interrupted before prions can colonize the brain via the optical pathway. Therefore the lack of graft infection following intraocular prion inoculation suggests that the absence of extracerebral PrP C impairs prion spread from extracerebral sites to the CNS, in addition to blocking neural spread.
Thus the intracerebral spread of prions is based on a PrP C -paved chain of cells, perhaps because such cells are capable of supporting prion replication [22,22a] . When such a chain is interrupted by interposed cells that lack PrP C , as in the case described here, no propagation of prions to the target tissue can occur. Perhaps prions require PrP C for propagation across synapses: PrP C is present in the synaptic region and certain synaptic properties are altered in Prnp o/o mice [30] . Perhaps transport of prions within (or on the surface of) neuronal processes is PrP C -dependent. Within the framework of the proteinonly hypothesis, these findings may be accommodated by a 'domino-effect' model, whereby the spread of scrapie prions in the CNS occurs continuously through the conversion of PrP C by adjacent PrP Sc [31] .
Cells in the CNS that are affected by spongiform encephalopathies
Transmissible spongiform encephalopathies show typical histopathological features in the CNS, such as vacuolization and reactive astrogliosis. Concurrent neuronal loss is frequently observed [32] , but in some instances (e.g. different strains of the agent) this feature is not obvious [33] and is detectable only after detailed morphometric analysis or in specific experimental systems [34] .
Mice expressing increased amounts of PrP C in their brains develop scrapie with a shortened incubation time after intracerebral scrapie infection (60 days, compared with 160 days in wild-type mice). However, the brains of these mice display remarkably little gliosis, no significant neuronal loss and very little accumulation of PrP Sc [22,22a,23] . In contrast, hemizygous mice carrying only one functional copy of the Prnp gene, and expressing approx. 50% of the PrP C found in wild-type mice, present with a relatively mild clinical course despite severe gliosis and more prominent neuronal loss.
A straightforward explanation for the above findings would be that a minimum period of time is required for PrP Sc to elicit neuronal impairment. On the other hand, the observation that PrP C expression levels (rather than the accumulation of PrP Sc ) correlate with the rate of clinical disease development suggests that neuronal damage may be the consequence of the conversion of PrP C into PrP Sc or some other agent.
In order to clarify the importance of these events, we again used grafting technology. Inoculated grafts developing a spongiform encephalopathy were kept viable for a period of time corresponding to seven times the lifespan of an infected donor mouse. This model enabled us to study the pathological chain of events leading to neurodegeneration, and to determine the end point of the disease. Of particular interest was the fate of neurons and astrocytes in scrapieinfected and degenerating grafts.
The first morphological changes in grafts characteristic of scrapie were detected 3 months after infection (Figure 3) . At this time, the neuropil displayed small vacuoles, a diffusely reduced granular synaptophysin immunoreactivity, and significant gliosis. Later (5-9 months after infection), large vacuoles and a dense accumulation of large synaptophysin granules around the neuron cell bodies were seen. At late stages (more than 9 months after inoculation), the grafts were almost completely devoid of neurons, while the main cell population was formed by densely clustered astrocytes.
Since BBB function relies on the interaction of astrocyte processes with the CNS endothelium, we investigated the functionality of the BBB during disease progression by means of gadolinium-enhanced MRI. The first MRI scan was obtained 2-3 months after the transplantation procedure, and showed full reconstitution of the BBB. Next, seven mice were inoculated intracerebrally with mouse prions and four mice with mock inoculum. All mice were scanned 2 months and 7 months later.
In seven mice with a tight BBB within the neural graft, scrapie infection resulted in a persistent disruption of the BBB (Figures 4b, 4e and 4h) , while no BBB leakage was observed in mock-infected grafted control mice (Figures 4c,  4f and 4i) . Post mortem analysis of the inoculated brains by immuno- histochemistry confirmed the presence of a graft with accumulation of proteinase-resistant protein (Figures 4j and 4k ), indicating that scrapie infection had taken place. In contrast, further control mice with clinical symptoms of scrapie showed no detectable BBB impairment. This is in contrast with previous findings in hamsters, which exhibited patchy BBB leakage upon gadolinium-enhanced MRI [35] , and in MRI studies of patients with CJD, which revealed increased signals in T2 weighted sequences (in which tissues with high water content appear bright) but no significant BBB disruption. These discrepancies may be ascribed to various factors. Since a functional BBB relies on intact astrocytic function and the interaction of astrocytic processes with blood vessel endothelia, the observed leakage in the transplantation model may be due to astrocytic damage. Indeed, strong gliosis occurs in the grafts 8-10 weeks after inoculation ( Figure 3) .
Perhaps scrapie affects the functional interaction of astrocytic end-feet with the vessel endothelium. It is known that this interaction contributes to BBB function. Interestingly, this putative functional impairment does not lead to the significant degeneration of astrocytes, which survive in large numbers until very late stages of disease in neural grafts. This is reflected by the persistence of BBB dysfunction in the grafting model during the incubation period, and is probably proportional to the extent of astrogliosis in the affected brain area. The very short latency between the onset of clinical symptoms and death, in combination with relatively mild gliosis, might explain why BBB dysfunction is not detectable in, for example, tga20 mice. In those models of scrapie in which gliosis is more prominent (e.g. the hamster, and our grafting model), astrocyte dysfunction becomes prominent and is detectable as BBB leakage by gadolinium-enhanced MRI.
The findings described here confirm several predictions about the formal pathogenesis of spongiform encephalopathies: (i) scrapie leads to the selective loss of neurons; (ii) astrocytes and perhaps other neuroectodermal cells, while being affected by the disease, can survive and maintain their phenotypic characteristics for very long periods of time; and (iii) proteinase-resistant protein accumulates in neuroectodermal tissue at all stages of the disease. It is unclear whether proteinase-resistant PrP accumulates due to continued production by the remaining cells (mainly astrocytes) or whether previously accumulated PrP is not cleared after PrP production has ceased. Recent transgenic studies [33] with mice expressing hamster PrP C under the control of a GFAP (the astrocyte intermediate-filament glial fibrillary acidic protein) promoter fragment have shown that astrocytes can support PrP Sc accumulation, replication of the scrapie agent and induction of the disease.
Disruption of BBB function has been reported in experimental hamster scrapie [35] , but has not been found in human spongiform encephalopathies. The localized BBB disruption in chronically infected grafts may contribute to the spread of prions from grafts to the surrounding brain which has been Essays in Biochemistry volume 33 1998 Mock inoculation, ϩ gadolinium described previously [22,22a] . This would account for the accumulation of proteinase-resistant PrP within the white matter and in brain areas surrounding the grafts. In view of the findings reported here, bulk-flow diffusion may be a mechanism contributing to prion spread as a consequence of prioninduced disruption of the BBB. 
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